Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation

International Archives of Allergy and Immunology

Volumn 154, Issue 3, 2011, Pages 227-235

  Haidl, Ian D ^a,b   McAlpine, Sarah M ^a,b   Marshall, Jean S ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Allergy; Cytokines; IL 6; Leukotrienes; Pattern recognition receptors; Peptidoglycan

Indexed keywords

ADENYLATE CYCLASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE C4; MURABUTIDE; MURAMYL DIPEPTIDE; N PALMITOYL S(2,3 BISPALMITOYLOXY PROPYL)CYSTEINYLSERYLLYSINE4; NAPROXEN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL;

GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MAST CELLS; NOD SIGNALING ADAPTOR PROTEINS; PEPTIDOGLYCAN; RECEPTORS, PATTERN RECOGNITION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS;

EID: 77956829871     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321109     Document Type: Article

References (46)

1. Dawicki W, Marshall JS: New and emerging roles for mast cells in host defence. Curr Opin Immunol 2007; 19: 31-38. (Pubitemid 46073696)
2. Sutherland ER, Martin RJ: Asthma and atypical bacterial infection. Chest 2007; 132: 1962-1966.
3. McNeil HP, Adachi R, Stevens RL: Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J Biol Chem 2007; 282: 20785-20789. (Pubitemid 47099891)
4. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 135-142. (Pubitemid 40268194)
5. Burke SM, Issekutz TB, Mohan K, Lee PW, Shmulevitz M, Marshall JS: Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 2008; 111: 5467-5476.
6. Sutherland RE, Olsen JS, McKinstry A, Villalta SA, Wolters PJ: Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol 2008; 181: 5598-5605.
7. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF: Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 1997; 176: 439-444. (Pubitemid 27328767)
8. Kawai T, Akira S: TLR signaling. Semin Immunol 2007; 19: 24-32. (Pubitemid 46498752)
9. Takeuchi O, Hoshino K, Akira S: Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165: 5392-5396.
10. McCurdy JD, Olynych TJ, Maher LH, Marshall JS: Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003; 170: 1625-1629. (Pubitemid 36197374)
11. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neumaier M, Renz H: The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004; 113: 565-567. (Pubitemid 38338967)
12. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I, Coskun M, Cilli A, Yegin O: The Arg753GLn polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219-223. (Pubitemid 38195506)
13. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrlander C, Nowak D, Martinez FD: Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113: 482-488. (Pubitemid 38338954)
14. Dziarski R, Platt KA, Gelius E, Steiner H, Gupta D: Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic Gram-positive bacteria in peptidoglycan recognition protein-S (PGRPS)-deficient mice. Blood 2003; 102: 689-697. (Pubitemid 36841993)
15. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509-5512. (Pubitemid 36800790)
16. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, Di-Stefano PS, Bertin J, Sansonetti PJ, Philpott DJ: Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003; 300: 1584-1587. (Pubitemid 36682892)
17. Strober W, Murray PJ, Kitani A, Watanabe T: Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6: 9-20. (Pubitemid 43279749)
18. Martinon F, Agostini L, Meylan E, Tschopp J: Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 2004; 14: 1929-1934. (Pubitemid 39464816)
19. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, Reed JC: Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007; 129: 45-56. (Pubitemid 46507581)
20. Carneiro LA, Magalhaes JG, Tattoli I, Philpott DJ, Travassos LH: Nod-like proteins in inflammation and disease. J Pathol 2008; 214: 136-148. (Pubitemid 351160152)
21. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke- Grauls CM, Appelmelk B, Van Kooyk Y: Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003; 197: 7-17. (Pubitemid 36110253)
22. Olynych TJ, Jakeman DL, Marshall JS: Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol 2006; 118: 837-843. (Pubitemid 44498745)
23. Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, Philpott DJ: Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007; 26: 445-459. (Pubitemid 46604867)
24. Tada H, Aiba S, Shibata K, Ohteki T, Takada H: Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 2005; 73: 7967-7976. (Pubitemid 41740282)
25. Watanabe T, Kitani A, Murray PJ, Strober W: NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800-808. (Pubitemid 39172973)
26. Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K, Matsumoto K, Iikura Y, Awaji T, Tsujimoto G, Yanagida M, Uzumaki H, Takahashi G, Tsuji K, Nakahata T: Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996; 157: 343-350. (Pubitemid 26190566)
27. Sahar S, Reddy MA, Wong C, Meng L, Wang M, Natarajan R: Cooperation of SRC-1 and p300 with NF- κB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007; 27: 1528-1534. (Pubitemid 46986106)
28. Song J, Duncan MJ, Li G, Chan C, Grady R, Stapleton A, Abraham SN: A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLOS Pathog 2007; 3: 541-552. (Pubitemid 46683489)
29. Leal-Berumen I, O'Byrne P, Gupta A, Richards CD, Marshall JS: Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. J Immunol 1995; 154: 4759-4767.
30. Rose MC, Voynow JA: Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006; 86: 245-278.
31. Nishimoto N, Kishimoto T: Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2006; 2: 619-626. (Pubitemid 44650950)
32. Krishnamoorthy N, Oriss TB, Paglia M, Fei M, Yarlagadda M, Vanhaesebroeck B, Ray A, Ray P: Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med 2008; 14: 565-573. (Pubitemid 351655220)
33. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F: Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-949. (Pubitemid 47300008)
34. Leal-Berumen I, Conlon P, Marshall JS: IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol 1994; 152: 5468-5476. (Pubitemid 24152996)
35. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R: Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003; 278: 17036-17043. (Pubitemid 36799579)
36. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. (Pubitemid 29084777)
37. Black S, Kushner I, Samols D: C-reactive Protein. J Biol Chem 2004; 279: 48487-48490. (Pubitemid 39625721)
38. van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, Ahmad T, McGovern DP, Onnie C, Negoro K, Goldthorpe S, Foxwell BM, Mathew CG, Forbes A, Jewell DP, Playford RJ: Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005; 365: 1794-1796. (Pubitemid 40744660)
39. Netea MG, Ferwerda G, de Jong DJ, Jansen T, Jacobs L, Kramer M, Naber TH, Drenth JP, Girardin SE, Kullberg BJ, Adema GJ, Van der Meer JW: Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 2005; 174: 6518-6523. (Pubitemid 40663847)
40. Travassos LH, Girardin SE, Philpott DJ, Blanot D, Nahori MA, Werts C, Boneca IG: Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 2004; 5: 1000-1006. (Pubitemid 39534459)
41. Kikawada E, Bonventre JV, Arm JP: Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2α activation. Blood 2007; 110: 561-567. (Pubitemid 47105394)
42. Peachell P: Regulation of mast cells by β-agonists. Clin Rev Allergy Immunol 2006; 31: 131-142.
43. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr, Muller W, Rudensky AY: Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28: 546-558.
44. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ: Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8: 1095-1104. (Pubitemid 47423757)
45. Nakano N, Nishiyama C, Kanada S, Niwa Y, Shimokawa N, Ushio H, Nishiyama M, Okumura K, Ogawa H: Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood 2007; 109: 4846-4855. (Pubitemid 46827781)
46. Varadaradjalou S, Feger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock M: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003; 33: 899-906. (Pubitemid 36546677)